Cargando…

Development of clinical diagnostic criteria for plaque psoriasis in children: an electronic Delphi consensus study with the International Psoriasis Council

Detalles Bibliográficos
Autores principales:	Burden‐Teh, E., Thomas, K. S., Gran, S., Murphy, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851710/ https://www.ncbi.nlm.nih.gov/pubmed/30972744 http://dx.doi.org/10.1111/bjd.17994

Ejemplares similares

Protocol for a case–control diagnostic accuracy study to develop diagnostic criteria for psoriasis in children (DIPSOC study): a multicentre study recruiting in UK paediatric dermatology clinics
por: Burden-Teh, Esther, et al.
Publicado: (2019)

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021)

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
por: Cohen, Arnon D., et al.
Publicado: (2020)

Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
por: Huang, He, et al.
Publicado: (2023)

Diagnostic criteria for erosive lichen planus affecting the vulva: an international electronic-Delphi consensus exercise
por: Simpson, RC, et al.
Publicado: (2013)

Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study)
por: Burden‐Teh, E., et al.
Publicado: (2021)

Accuracy of dermoscopic and reflectance confocal microscopic criteria for diagnosis of psoriasis
por: Wang, Zi-Yi, et al.
Publicado: (2020)

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
por: Burlando, Martina, et al.
Publicado: (2022)

Basic Therapeutic Approach for Patients with Plaque Psoriasis: Korean Expert Consensus Using the Modified Delphi Method
por: Jo, Seong Jin, et al.
Publicado: (2023)

Anti-Programmed Cell Death-1-Induced Plaque and Guttate Psoriasis
por: Yamamoto, Toshiyuki
Publicado: (2018)

Inflammasome Related Mediators and Their Association with Disease Determinants in Chronic Plaque Psoriasis
por: Chhabra, Seema, et al.
Publicado: (2021)

Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
por: Zhang, Si, et al.
Publicado: (2022)

Secukinumab for Recalcitrant Chronic Plaque Psoriasis in a 9 Year Old Child
por: Shruthi, R, et al.
Publicado: (2021)

Pseudoainhum in Psoriasis
por: Kumar, Pradeep, et al.
Publicado: (2012)

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement
por: Fargnoli, Maria Concetta, et al.
Publicado: (2023)

Getting under the Skin: Report from the International Psoriasis Council Workshop on the Role of Stress in Psoriasis
por: Schwartz, Julia, et al.
Publicado: (2016)

Guselkumab for plaque psoriasis
Publicado: (2019)

Bimekizumab for plaque psoriasis
Publicado: (2022)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Can atopic eczema and psoriasis coexist? A systematic review and meta‐analysis
por: Cunliffe, A., et al.
Publicado: (2021)

Dermoscopic features of acutely exacerbated plaque psoriasis induced by anti-programmed death-1 for lung cancer
por: Sui, Chang-Lin, et al.
Publicado: (2020)

Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy
por: Imafuku, Shinichi, et al.
Publicado: (2018)

Effectiveness and safety of secukinumab in Chinese patients with plaque psoriasis in a clinical practice setting: a pilot study
por: Zhu, Si-Man, et al.
Publicado: (2020)

Beating Palmoplantar Psoriasis Away
por: D’Souza, Paschal V
Publicado: (2012)

Serum Omentin-1 in Psoriasis
por: Bakry, Ola Ahmed, et al.
Publicado: (2018)

Updates in psoriasis diagnosis and treatment status in China: results from the National Psoriasis Center Registry
por: Yang, Zhihui, et al.
Publicado: (2023)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008)

Freedom from disease in psoriasis: a Delphi consensus definition by patients, nurses and physicians
por: van Ee, I., et al.
Publicado: (2021)

Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology
por: Arnone, Marcelo, et al.
Publicado: (2019)

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
por: Strober, Bruce, et al.
Publicado: (2019)

Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
por: Gisondi, Paolo, et al.
Publicado: (2021)

Goa Powder as a Remedy in Psoriasis
por: Ram, Sobha
Publicado: (1878)

Goa Powder as a Remedy in Psoriasis
por: Ringer, Theobald
Publicado: (1877)

A Case of Psoriasis Encircled by Porokeratosis
por: Podder, Indrashis, et al.
Publicado: (2016)

Online decision aid for patients with psoriasis
por: van der Kraaij, G.E., et al.
Publicado: (2021)

Oral Psoriasis – A Rare Entity
por: Lobo, Carol, et al.
Publicado: (2022)

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1
por: Strober, Bruce E., et al.
Publicado: (2012)

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2
por: Strober, Bruce E., et al.
Publicado: (2012)

Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method
por: Richard, Marie-Aleth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_er5svk64ct67b102ggagvnpdjq